Rheb's role in cancer

Aug 14, 2008

Two independent papers in the August 15th issue of G&D identify the Rheb GTPase as a novel oncogene and a promising new chemotherapeutic target.

The first paper, from Dr. Pier Paolo Pandolfi (BIDMC and Harvard Medical School) and colleagues, demonstrates that the Ras-like small GTPase, Rheb, is directly involved in prostate tumorigenesis.

Through the overexpression of Rheb specifically in prostate tissue of live mice, the researchers were able to show that increased Rheb signaling activity is sufficient to induce low-grade prostate neoplasias. Furthermore, in combination with decreased PTEN activity, Rheb overexpression can stimulate aggressive prostate tumor formation.

"The identification of Rheb as a gene involved in the pathogenesis of cancer opens new avenues for the development of anti-cancer therapies, as Rheb is an inherently 'druggable' target. Indeed, we are already testing such drugs alone, and in combination with other chemotherapeutics in faithful animal models," explains Dr. Pandolfi.

In the accompanying paper, Dr. Hans-Guido Wendel (Memorial Sloan Kettering Cancer Center) and colleagues present evidence that Rheb can also function as an oncogene in lymphomagenesis.

Using an experimental animal model of human lymphoma, the researchers demonstrated that Rheb overexpression contributes to lymphoma formation. They also pinpointed Rheb overexpression as a naturally occurring genetic mutation in human patient-derived lymphoma tumor samples. In addition, Dr. Wendel and colleagues found that the targeted inhibition of Rheb can effectively counteract tumor progression in lymphomas with this unique genetic signature.

Dr. Wendel emphasizes that "The key clinical implication is that Rheb levels in tumor tissue could indicate patients that will benefit from relatively non-toxic therapies with targeted drugs like rapamyicn or inhibitors of the farnesyltransferase enzyme."

Source: Cold Spring Harbor Laboratory

Explore further: Researchers find chemotherapy after bladder cancer surgery improved survival

add to favorites email to friend print save as pdf

Related Stories

Warming up the world of superconductors

23 minutes ago

A superconductor that works at room temperature was long thought impossible, but scientists at USC may have discovered a family of materials that could make it reality.

Isolated wetlands have significant impact on water quality

24 minutes ago

Geographically isolated wetlands play an outsized role in providing clean water and other environmental benefits even though they may lack the regulatory protections of other wetlands, according to an article by Indiana University ...

Epigenetic 'switch' regulates RNA-protein interactions

24 minutes ago

Chemical changes - also known as epigenetic modifications - to messenger RNA (mRNA) are thought to play an important role in gene expression, and have recently been found to affect biological processes such as circadian clock ...

Monster black hole discovered at cosmic dawn

24 minutes ago

Scientists have discovered the brightest quasar in the early universe, powered by the most massive black hole yet known at that time. The international team led by astronomers from Peking University in China ...

Recommended for you

Deodorant use ok for radiotherapy patients

Feb 27, 2015

Women undergoing radiotherapy for breast cancer can use deodorant without fear of increased underarm skin reaction, pain, itching or burning, research suggests.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.